Diverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201

MIAMI–(BUSINESS WIRE)– #CBD–Diverse Biotech has been granted USPTO patent approval of its novel CUSP synthesis platform creating an entirely new class of drugs that are part-antibody and part-cannabinoid in one new molecule. Starting with DBT-50201, its novel PEMBROLIZUMAB compound, Diverse expects to develop multiple treatments for many diseases with highly ... Read More

CORRECTING and REPLACING Brown-Forman Reports First Quarter Fiscal 2024 Results; Reaffirms Full Year Outlook

LOUISVILLE, Ky.–(BUSINESS WIRE)–Schedule D Supplemental Information should read: Developed International (3%), Emerging 1%, Travel Retail 3% (instead of Developed International 1%, Emerging 3%, Travel Retail (1%).) The updated release reads: BROWN-FORMAN REPORTS FIRST QUARTER FISCAL 2024 RESULTS; REAFFIRMS FULL YEAR OUTLOOK Brown-Forman Corporation (NYSE: BFA, BFB) reported financial results for ... Read More

Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced that it will be giving an investor presentation at the H.C. Wainwright 25th Annual Global Investment Conference, from September ... Read More

Enveric Biosciences to Present at H.C. Wainwright 25th Annual Global Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will deliver a virtual presentation at the H.C. Wainwright 25th ... Read More

Elmhurst® 1925 Announces Its Newest Seasonal Offering, Apple Pie Spice Seasonal Blend, Alongside Returning Fan Favorite LTOs

ELMA, N.Y.–(BUSINESS WIRE)–Elmhurst® 1925, maker of simple, nutritious and incredibly delicious plant-based dairy products, is introducing limited-edition Apple Pie Spice Blend to its beloved seasonal collection, which also features returning fan-favorites Pumpkin Spice Oat Creamer and OatNog™. All three limited-edition seasonals are now available for purchase as shoppers gear up ... Read More